<?xml version="1.0" encoding="UTF-8"?>
<ref id="B62-marinedrugs-17-00373">
 <label>62.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Hao</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Jiao</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Shan</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Tai</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Inhibition of influenza A virus infection by fucoidan targeting viral neuraminidase and cellular EGFR pathway</article-title>
  <source>Sci. Rep.</source>
  <year>2017</year>
  <volume>7</volume>
  <fpage>40760</fpage>
  <pub-id pub-id-type="doi">10.1038/srep40760</pub-id>
  <?supplied-pmid 28094330?>
  <pub-id pub-id-type="pmid">28094330</pub-id>
 </element-citation>
</ref>
